Fig. 4.

Plasma levels of cytokine-induced neutrophil chemoattractant 2 (CINC-2), vascular endothelial growth factor (VEGF), interleukin (IL)-6 and tumour necrosis factor (TNF)-α determined by xMAP technology. The results obtained from plasma samples of animals during tumour progression or regression are presented as mean ± standard error per group. (a) Significance P < 0·05 in comparison to healthy controls, (b) significance P < 0·05 in comparison to samples obtained from tumour progressing animals.